Potent and selective in vitro activity of 3' -deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (17), 2713-2718
- https://doi.org/10.1016/0006-2952(87)90253-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- 3′-Hydroxymethyl 2′-deoxynucleoside 5′-triphosphates are inhibitors highly specific for reverse transcriptaseFEBS Letters, 1986
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Antiviral Drugs for AIDSDrugs, 1986
- Synthetic Antiviral AgentsChemical & Engineering News, 1986
- RIFABUTINE INHIBITS HTLV-IIIThe Lancet, 1986
- IN-VITRO INHIBITION OF LAV/HTLV-III INFECTED LYMPHOCYTES BY DITHIOCARB AND INOSINE PRANOBEXThe Lancet, 1985
- Effects of a Novel Compound (AL 721) on HTLV-III Infectivity in VitroNew England Journal of Medicine, 1985
- ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROMEThe Lancet, 1985
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979